Cryo-Cell International (CCEL) Stock Price, Quote, News & History

Q: What sector and industry does Cryo-Cell International (CCEL) operate in?

Cryo-Cell International is in the Health Care sector and Health Care Providers & Services industry. They are listed on the AMEX.

Cryo-Cell International Inc (CCEL) Stock Price, Quote, News & History

CCELAMEX

Trade with Public

$3.37

-0.01-0.30%

At close: Feb 9, 4:00 PM EST

$3.25

-0.12-3.56%

After Hours: Feb 6, 5:14 PM EST

Key Statistics

Open

$3.44

$3.37

Volume / Avg.

14.73K / 10.18K

Day Range

$3.11 - $3.55

52 Wk Range

3.10 - 8.79

Market Cap

$27.15M

P/E Ratio

Dividend Yield

17.80%

Exchange

AMEX

RSI

Short Interest

0.13%

Days to Cover

Recent Cryo-Cell International Inc News

Why KalVista Pharmaceuticals Shares Are Trading Lower By 59%; Here Are 89 Biggest Movers From Yesterday

Losers

Lisa Levin

Why Korn Ferry Is Trading Lower By Over 8%, Here Are 40 Stocks Moving In Wednesday's Mid-Day Session

Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) jumped 64% to $0.1199. Allena Pharmaceuticals shares dipped over 30% on Tuesday after the company announced it has filed for bankruptcy.

Lisa Levin

40 Stocks Moving In Wednesday's Mid-Day Session

Gainers US Ecology, Inc. (NASDAQ: ECOL) shares jumped 68.1% to $47.34 after Republic Services reported it will buy the company at $48 per share in cash.

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

6.35M

Investing Cash Flow (TTM)

-1.80M

Financing Cash Flow (TTM)

-4.49M

Free Cash Flow (TTM)

6.05M

Capital Expenditure (TTM)

-304.93K

Net Change in Cash (TTM)

67.77K

Analyst Trends and Forecast

Oct 25

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$36.60M

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

0.86

PB Ratio (TTM)

Earnings Yield % (TTM)

-1.78%

Earnings Yield % (FWD)

EV / EBITDA (TTM)

7.08

Price / EBITDA (TTM)

5.31

Price / Free Cash Flow (TTM)

4.53

Book Value / Share

-$1.84

Company Debt

Total Debt

$11.59M

LT Debt

$8.21M

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

-$140.19K

Total Cash

$265.21K

Debt to Equity

Issuance of Debt (TTM)

-$140.19K

Repayment of Debt (TTM)

-$7.98M

Key Statistics

Open

$3.44

$3.37

Volume / Avg.

14.73K / 10.18K

Day Range

$3.11 - $3.55

52 Wk Range

3.10 - 8.79

Market Cap

$27.15M

P/E Ratio

Dividend Yield

17.80%

Exchange

AMEX

RSI

Short Interest

0.13%

Days to Cover

About

Sector

Health Care

Industry

Health Care Providers & Services

Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilica...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Cryo-Cell International (CCEL) stock?

You can purchase shares of Cryo-Cell International (AMEX:CCEL) through any online brokerage.

View our list of the best stock brokerages

Who are Cryo-Cell International (CCEL) competitors?

Other companies in Cryo-Cell International’s space includes: Prenetics Global Ltd (NASDAQ:PRENW), Precipio Inc (NASDAQ:PRPO), rYojbaba Co Ltd (NASDAQ:RYOJ), SBC Medical Group Holdings Inc (NASDAQ:SBCWW) and Agilon Health Inc (NYSE:AGL).

What is the forecast, or price target, for Cryo-Cell International (CCEL) stock?

There is no analysis for Cryo-Cell International to provide a consensus price target.

What is the current price for Cryo-Cell International (CCEL)?

The stock price for Cryo-Cell International (AMEX: CCEL) is $3.37 last updated February 9, 2026 at 8:00 PM EST.

Does Cryo-Cell International (CCEL) pay a dividend?

There are no upcoming dividends for Cryo-Cell International.

When is Cryo-Cell International (AMEX:CCEL) reporting earnings?

Cryo-Cell International does not have any upcoming earnings scheduled.

Is Cryo-Cell International (CCEL) going to split?

There is no upcoming split for Cryo-Cell International.

What sector and industry does Cryo-Cell International (CCEL) operate in?

Cryo-Cell International is in the Health Care sector and Health Care Providers & Services industry. They are listed on the AMEX.

People Also Watch

SBC Medical Group Holdings Inc

American Shared Hospital Services

AMEX:AMS

$2.16

0.47%

Mobile-health Network Solutions

NASDAQ:MNDR

$0.98

-2.96%

Vivos Therapeutics Inc

NASDAQ:VVOS

$1.70

0.59%

Key Statistics

Open

$3.44

$3.37

Volume / Avg.

14.73K / 10.18K

Day Range

$3.11 - $3.55

52 Wk Range

3.10 - 8.79

Market Cap

$27.15M

P/E Ratio

Dividend Yield

17.80%

Exchange

AMEX

RSI

Short Interest

0.13%

Days to Cover

Recent Cryo-Cell International Inc News

Why KalVista Pharmaceuticals Shares Are Trading Lower By 59%; Here Are 89 Biggest Movers From Yesterday

Losers

Lisa Levin

Why Korn Ferry Is Trading Lower By Over 8%, Here Are 40 Stocks Moving In Wednesday's Mid-Day Session

Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) jumped 64% to $0.1199. Allena Pharmaceuticals shares dipped over 30% on Tuesday after the company announced it has filed for bankruptcy.

Lisa Levin

40 Stocks Moving In Wednesday's Mid-Day Session

Gainers US Ecology, Inc. (NASDAQ: ECOL) shares jumped 68.1% to $47.34 after Republic Services reported it will buy the company at $48 per share in cash.

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

6.35M

Investing Cash Flow (TTM)

-1.80M

Financing Cash Flow (TTM)

-4.49M

Free Cash Flow (TTM)

6.05M

Capital Expenditure (TTM)

-304.93K

Net Change in Cash (TTM)

67.77K

Analyst Trends and Forecast

Oct 25

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$36.60M

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

0.86

PB Ratio (TTM)

Earnings Yield % (TTM)

-1.78%

Earnings Yield % (FWD)

EV / EBITDA (TTM)

7.08

Price / EBITDA (TTM)

5.31

Price / Free Cash Flow (TTM)

4.53

Book Value / Share

-$1.84

Company Debt

Total Debt

$11.59M

LT Debt

$8.21M

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

-$140.19K

Total Cash

$265.21K

Debt to Equity

Issuance of Debt (TTM)

-$140.19K

Repayment of Debt (TTM)

-$7.98M

Key Statistics

Open

$3.44

$3.37

Volume / Avg.

14.73K / 10.18K

Day Range

$3.11 - $3.55

52 Wk Range

3.10 - 8.79

Market Cap

$27.15M

P/E Ratio

Dividend Yield

17.80%

Exchange

AMEX

RSI

Short Interest

0.13%

Days to Cover

About

Sector

Health Care

Industry

Health Care Providers & Services

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry